OCULAR THERAPEUTIX INC's ticker is OCUL and the CUSIP is 67576A100. A total of 80 filers reported holding OCULAR THERAPEUTIX INC in Q4 2019. The put-call ratio across all filers is 0.24 and the average weighting 1.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $41,000 | +13.9% | 10,137 | -0.5% | 0.00% | – |
| Q1 2022 | $36,000 | -50.7% | 10,187 | -2.8% | 0.00% | – |
| Q4 2021 | $73,000 | -32.4% | 10,476 | -3.0% | 0.00% | – |
| Q3 2021 | $108,000 | -32.1% | 10,799 | -3.4% | 0.00% | – |
| Q2 2021 | $159,000 | -99.4% | 11,180 | -99.3% | 0.00% | -100.0% |
| Q1 2021 | $25,414,000 | +13.0% | 1,548,627 | +42.5% | 0.03% | +4.0% |
| Q4 2020 | $22,496,000 | +31144.4% | 1,086,772 | +7314.2% | 0.02% | – |
| Q1 2020 | $72,000 | +227.3% | 14,658 | +106.0% | 0.00% | – |
| Q3 2019 | $22,000 | – | 7,115 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SV Health Investors, LLC | 1,932,607 | $40,643,000 | 15.56% |
| Lamond Capital Partners LLC | 711,533 | $14,964,000 | 15.19% |
| Polaris Venture Management Co. V, L.L.C. | 1,230,009 | $25,867,000 | 11.54% |
| NOTTINGHAM ADVISORS, INC. | 171,985 | $3,617,000 | 0.60% |
| Portolan Capital Management | 122,518 | $2,577,000 | 0.36% |
| SPHERA FUNDS MANAGEMENT LTD. | 160,000 | $3,365,000 | 0.33% |
| Rotella Capital Management, Inc. | 18,461 | $388,000 | 0.32% |
| Monashee Investment Management LLC | 28,834 | $606,000 | 0.29% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 335,498 | $7,056,000 | 0.24% |
| BAILARD, INC. | 55,000 | $1,157,000 | 0.18% |